While anti-PD-L1 antibody treatment successfully retarded tumor growth and prolonged mouse survival in CT26 P0 tumor-bearing mice, there were no remarkable therapeutic effects in CT26 P3 tumor-bearing mice (Supplementary Fig. 6a, b). Here, CD274 is linked to neoplasm.